New evolution-busting drug overcomes resistance in aggressive breast cancers
A new type of drug that blocks one of cancer's key evolutionary escape routes from chemotherapy has been shown to reinvigorate the response to chemotherapy in cancers that had become resistant. The drug, BOS172722, works by forcing cancer cells through cell division too quickly, leading to fatal errors.